Advancing the Use of Direct Oral Anticoagulants in Left Ventricular Thrombus Management.
作者信息
Carvalho Pedro E P
机构信息
Center for Coronary Artery Disease - Minneapolis Heart Institute Foundation, Minneapolis - EUA.
出版信息
Arq Bras Cardiol. 2024 Aug 26;121(7):e20240409. doi: 10.36660/abc.20240409. eCollection 2024.
Abstract
摘要
相似文献
1
Advancing the Use of Direct Oral Anticoagulants in Left Ventricular Thrombus Management.推进直接口服抗凝剂在左心室血栓管理中的应用。
Arq Bras Cardiol. 2024 Aug 26;121(7):e20240409. doi: 10.36660/abc.20240409. eCollection 2024.
2
Use of direct oral anticoagulants in patients with left ventricular thrombus.左心室血栓患者使用直接口服抗凝剂的情况。
Eur J Intern Med. 2024 Aug;126:132-133. doi: 10.1016/j.ejim.2024.04.018. Epub 2024 Apr 27.
3
A meta-analysis of direct oral anticoagulants vs warfarin for left ventricular thrombus.
Prog Cardiovasc Dis. 2024 Jul-Aug;85:114-117. doi: 10.1016/j.pcad.2024.03.005. Epub 2024 Mar 27.
4
Silent embolization of a large left ventricular thrombus.
Arch Cardiovasc Dis. 2010 Jan;103(1):59-60. doi: 10.1016/j.acvd.2009.08.005. Epub 2009 Nov 27.
5
Complete lysis of left ventricular giant thrombus with anticoagulation therapy alone.单纯抗凝治疗使左心室巨大血栓完全溶解。
Clin Cardiol. 2009 Jul;32(7):E38-9. doi: 10.1002/clc.20123.
6
Resolution of a large left ventricular thrombus with anticoagulation alone.单纯抗凝治疗使巨大左心室血栓溶解。
Saudi Med J. 2005 Sep;26(9):1445-8.
7
Comparative Study of Oral Anticoagulation in Left Ventricular Thrombi (No-LVT Trial).左心室血栓口服抗凝治疗的比较研究（无左心室血栓试验）
J Am Coll Cardiol. 2021 Mar 30;77(12):1590-1592. doi: 10.1016/j.jacc.2021.01.049.
8
Resolution of left ventricular thrombus with apixaban in a patient with hypertrophic cardiomyopathy.阿哌沙班治疗肥厚型心肌病患者左心室血栓的疗效
Turk Kardiyol Dern Ars. 2016 Jun;44(4):335-7. doi: 10.5543/tkda.2015.68054.
9
Evaluation of the safety and efficacy of direct oral anticoagulants compared with vitamin-k antagonists in the treatment of left ventricular thrombosis. A systematic review and meta-analysis.评价直接口服抗凝剂与维生素 K 拮抗剂治疗左心室血栓的安全性和有效性：系统评价和荟萃分析。
Heart Lung. 2024 Sep-Oct;67:121-136. doi: 10.1016/j.hrtlng.2024.04.019. Epub 2024 May 15.
10
Use of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: Systematic Review of Current Literature.直接口服抗凝剂在左心室血栓治疗中的应用：当前文献的系统评价。
Am J Ther. 2020 Nov/Dec;27(6):e584-e590. doi: 10.1097/MJT.0000000000000937.
本文引用的文献
1
Direct Oral Anticoagulants versus Vitamin K Antagonists for Left Ventricular Thrombus: A Meta-Analysis with Trial Sequential Analysis.直接口服抗凝剂与维生素 K 拮抗剂治疗左心室血栓：一项荟萃分析与试验序贯分析。
Arq Bras Cardiol. 2024 Jun;121(7):e20230738. doi: 10.36660/abc.20230738.
2
Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials.直接口服抗凝剂与维生素 K 拮抗剂在抗磷脂综合征患者中的比较：随机试验的荟萃分析。
J Am Coll Cardiol. 2023 Jan 3;81(1):16-30. doi: 10.1016/j.jacc.2022.10.008. Epub 2022 Oct 31.
3
Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association.左心室血栓风险患者及左心室血栓患者的管理：美国心脏协会科学声明
Circulation. 2022 Oct 11;146(15):e205-e223. doi: 10.1161/CIR.0000000000001092. Epub 2022 Sep 15.
4
Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation.利伐沙班在风湿性心脏病相关心房颤动中的应用。
N Engl J Med. 2022 Sep 15;387(11):978-988. doi: 10.1056/NEJMoa2209051. Epub 2022 Aug 28.
5
Prophylactic Rivaroxaban Therapy for Left Ventricular Thrombus After Anterior ST-Segment Elevation Myocardial Infarction.前壁ST段抬高型心肌梗死后左心室血栓的利伐沙班预防性治疗
JACC Cardiovasc Interv. 2022 Apr 25;15(8):861-872. doi: 10.1016/j.jcin.2022.01.285. Epub 2022 Mar 30.
6
Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.非标准可调节风险因素的 STEMI 患者的死亡率：SWEDEHEART 注册研究数据的性别细分分析。
Lancet. 2021 Mar 20;397(10279):1085-1094. doi: 10.1016/S0140-6736(21)00272-5. Epub 2021 Mar 9.
7
Incidence and predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: a meta-analysis.急性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后心血管磁共振检测左心室血栓的发生率及预测因素：荟萃分析。
J Cardiovasc Magn Reson. 2018 Nov 8;20(1):72. doi: 10.1186/s12968-018-0494-3.
8
Edoxaban versus warfarin in patients with atrial fibrillation.依度沙班与华法林用于房颤患者。
N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19.
9
Recent pharmacological advances for treating venous thromboembolism: are we witnessing the demise of warfarin?最近在治疗静脉血栓栓塞症方面的药理学进展：我们是否正在见证华法林的消亡？
J R Soc Med. 2013 Nov;106(11):441-6. doi: 10.1177/0141076813498232. Epub 2013 Sep 11.
10
Dabigatran versus warfarin in patients with mechanical heart valves.达比加群酯与华法林用于机械心脏瓣膜患者的比较。
N Engl J Med. 2013 Sep 26;369(13):1206-14. doi: 10.1056/NEJMoa1300615. Epub 2013 Aug 31.
Zotero 插件